Fig. 2From: MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis a Change in myeloid related protein (MRP)8/14 serum levels in non-responders pre-treatment compared to levels after treatment for an average of 3.2Â months. b Change in MRP8/14 serum levels in responders pre-treatment compared to levels after treatment for an average of 3.2Â monthsBack to article page